SCHEMBL4038768

SCHEMBL4038768

Nc1ncccc1C1(C(C(=O)NC2CCCCC2)C2CCCCC2)Nc2ccccc2N1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.41
KDM4E B2RXH2 1/20 0.41
GAA P10253 1/20 0.41
C3AR1 Q16581 1/20 0.38
MEN1 O00255 3/20 0.38
KMT2A Q03164 3/20 0.38
RAB9A P51151 1/20 0.38
EGFR P00533 1/20 0.38
ERBB2 P04626 1/20 0.38
MET P08581 1/20 0.38
KDR P35968 1/20 0.38
MERTK Q12866 1/20 0.38
MAPT P10636 1/20 0.37
CYP1A2 P05177 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2C9 P11712 1/20 0.37
CYP2C19 P33261 1/20 0.37
HTT P42858 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
CNR2 P34972 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4040357 1.00 ALDH1A1 (0.41) ALDH1A1KDM4EGAAC3AR1MEN1
SCHEMBL4041730 0.86 C3AR1 (0.46) ALDH1A1KDM4EGAAC3AR1MEN1
SCHEMBL4035291 0.84 EGFR (0.42) ALDH1A1KDM4EGAAMEN1KMT2A
SCHEMBL4039455 0.83 KMT2A (0.48) ALDH1A1KDM4EC3AR1MEN1KMT2A
SCHEMBL4036317 0.83 HPGD (0.43) ALDH1A1KDM4EGAAC3AR1MEN1
SCHEMBL4036690 0.81 TSHR (0.43) ALDH1A1KDM4EGAAMEN1KMT2A
SCHEMBL4034668 0.81 IDO1 (0.43) ALDH1A1KDM4EGAAKMT2ARAB9A
SCHEMBL4044888 0.81 KMT2A (0.45) ALDH1A1KDM4EC3AR1MEN1KMT2A
SCHEMBL4044962 0.81 KMT2A (0.49) ALDH1A1KDM4EC3AR1MEN1KMT2A
SCHEMBL4037453 0.80 EPHX1 (0.43) ALDH1A1KDM4EGAAMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2038259-A1 BENZIMIDAZOLE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, THEIR USE AS FXR AGONISTS AND PHARMACEUTICAL PREPARATIONS CONTAINING THE SAME F.HOFFMANN-LA ROCHE AG (CH) 2009-03-25 EP claimed
WO-2008000643-A1 BENZIMIDAZOLE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, THEIR USE AS FXR AGONISTS AND PHARMACEUTICAL PREPARATIONS CONTAINING THE SAME F. HOFFMANN-LA ROCHE AG (CH) 2008-01-03 WO claimed
EP-3043865-A1 METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF HEPATITIS B VIRUS INFECTION Institut National de la Santé et de la Recherche Médicale (INSERM) (FR) 2016-07-20 EP disclosed
WO-2015036442-A1 METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF HEPATITIS B VIRUS INFECTION INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) 2015-03-19 WO disclosed
EP-2038259-A1 BENZIMIDAZOLE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, THEIR USE AS FXR AGONISTS AND PHARMACEUTICAL PREPARATIONS CONTAINING THE SAME F.HOFFMANN-LA ROCHE AG (CH) 2009-03-25 EP disclosed
WO-2008000643-A1 BENZIMIDAZOLE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, THEIR USE AS FXR AGONISTS AND PHARMACEUTICAL PREPARATIONS CONTAINING THE SAME F. HOFFMANN-LA ROCHE AG (CH) 2008-01-03 WO disclosed